Asston Pharmaceuticals Ltd IPO

Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African and Asian markets. Presently our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion), and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. As on the date of this Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis. Our Company basically gives contract for manufacturing the products to WHO-GMP certified contract manufacturers and FDA-accredited laboratories, ensuring adherence to industry standards from production to export. From manufacturing to exports and distributions, our Company takes responsibility and oversees each phase of the supply chain.

Open Demat Account

50years

Asston Pharmaceuticals Ltd IPO Details

Details

Total Shares OfferedOffer to PublicRetail Max (Shares)Pre Issue Promoters HoldingExchangeIssue size
₹ 22.41 LTBATBATBADBC₹ 27.56 Cr
IPO Open DateClose DateLot SizeMin InvestmentIssue TypeListing Date
09 Jul, 2511 Jul, 251000 ₹ 1,15,000 Book Building - SME16 Jul, 25

Asston Pharmaceuticals Ltd IPO Dates

  • 09 Jul 2025

    Opening date

  • 11 Jul 2025

    Closing date

  • 14 Jul 2025

    Basis of
    Allotment

  • 15 Jul 2025

    Initiation of
    Refunds

  • 15 Jul 2025

    Credit of
    Shares

  • 16 Jul 2025

    Listing date

Details

SectorType
SectorPharmaceuticals - Indian - Bulk Drugs
Sub SectorNA
Issue TypeBook Building - SME

Subscription Status

*Values are in Lakhs

Investor TypeSubscription TimesShares Offered*Shares Bid*
QIB0x00
NII0x00
Retail0x00
Employee0x00
Total0x22410000

Subscription Status

Investor Type

QIB

NII

Retail

Employee

Total

*Values are in Lakhs

Asston Pharmaceuticals Ltd Financial Status

Income Statement

Balance Sheet

Particulars (in Rs. Crores)FY23FY22FY21
Revenue from operations1.871.450.17
EBITDA1.921.490.18
PAT1.361.060.11
Total Assets18.3410.697.38
Share Capital0.780.700.70
Total Borrowings4.694.513.30
Operating Activities (Net Cash)1.411.100.12
Investing Activities (Net Cash)0.000.000.00
Financing Activities (Net Cash)4.694.513.30
Net Cashflow0.010.120.14

Particulars (in Rs. Crores)

Revenue from operations

EBITDA

PAT

Total Assets

Share Capital

Total Borrowings

Operating Activities (Net Cash)

Investing Activities (Net Cash)

Financing Activities (Net Cash)

Net Cashflow

About Asston Pharmaceuticals Ltd

Our Company was originally incorporated as Asston Pharmaceuticals Private Limited, a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, our Company was converted into a public limited company and the name of our Company was changed from Asston Pharmaceuticals Private Limited to Asston Pharmaceuticals Limited vide fresh certificate of incorporation dated August 29, 2024 issued by the Registrar of Companies, Mumbai, Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.

Indian pharmaceutical industry has a strong presence at the global level. Pharmacy of the world as it is often called offers around 60,000 generic brands across 60 therapeutic categories, accounting for 20 per cent of global generic drug exports by volume. Not surprisingly, eight of the top 20 global generic companies are based in India. Indian pharmaceutical industry is known for its generic medicines and low-cost vaccines globally. Transformed over the years as a vibrant sector, presently Indian Pharma ranks third in pharmaceutical production by volume. The Pharmaceutical industry in India is the third largest in the world in terms of volume and 14th largest in terms of value. The Pharma sector currently contributes to around 1.72% of the country's GDP.

Our Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African and Asian markets. Presently our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion), and Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, our Company also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. As on the date of this Red Herring Prospectus, we cater to multiple corporate clients on loan licence and/or contract manufacturing basis. Our Company basically gives contract for manufacturing the products to WHO-GMP certified contract manufacturers and FDA-accredited laboratories, ensuring adherence to industry standards from production to export. From manufacturing to exports and distributions, our Company takes responsibility and oversees each phase of the supply chain.

Asston Pharmaceuticals Ltd IPO Key Points

Strengths

  • Formulation Expertise.
  • Experienced Promoters.
  • Wide range of Products.
  • Strategic Location.
  • Skilled Workforce.

Risk

  • The Company operates in pharmaceutical sector, which is extensively regulated, any failures on its part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financial condition.
  • The company operate its own manufacturing facility for pharmaceutical products; however for certain products other than tablets, the company relies on third-party manufacturers to procure the pharmaceutical products.
  • The company depends on the success of its relationships with the company customers. The company derives a significant part of its revenue from its major customers and the company does not have long-term contracts with these customers other than contracts with 2 customers for one year. If one or more of such customers choose not to source their requirements from it, the company business, financial condition and results of operations may be adversely affected.

Strategy

  • Expanding our footprint.
  • Expanding our product offerings.
  • Increase our warehouse capabilities.
  • Increase the numbers of contract manufacturers.
  • Investment and upgradation in Information Technology (IT) and other digital initiatives.
  • Formulation Expertise.
  • Experienced Promoters.
  • Wide range of Products.
  • Strategic Location.
  • Skilled Workforce.

How To Apply for Asston Pharmaceuticals Ltd IPO Online?

Step 1:

Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

Get your FAQs right

Asston Pharmaceuticals Ltd's IPO offers shares for up to ₹ 0 L It begins on Jul 9, 2025 and ends on Jul 11, 2025.

The price of Asston Pharmaceuticals Ltd IPO ranges between ₹115 to ₹123 per share.

The Asston Pharmaceuticals Ltd IPO opens on Jul 9, 2025 and closes on Jul 11, 2025.

The allotment for the Asston Pharmaceuticals Ltd IPO will be finalised on Jul 14, 2025. The shares will be listed on BSE and NSE on Jul 16, 2025.

The minimum lot size for Asston Pharmaceuticals Ltd IPO is 1000 shares, priced between ₹115 to ₹123 per share.

The GMP (Grey Market Premium) of Asston Pharmaceuticals Ltd IPO fluctuates based on market demand and sentiment.

To check the allotment status of Asston Pharmaceuticals Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

The Asston Pharmaceuticals Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Jul 9, 2025, and closes on Jul 11, 2025. The allotment is finalised on Jul 14, 2025.

To apply for the Asston Pharmaceuticals Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.